DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • South Korea
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
A464280 logo

Tdspharm Co., Ltd. Stock Price

KOSDAQ:A464280 Community·₩30.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

A464280 Share Price Performance

₩5,520.00
-4880.00 (-46.92%)
​
₩5,520.00
-4880.00 (-46.92%)
​
Price ₩5,520.00
Fri, 11 Sep 26
Share Pricen/a

A464280 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

2 Risks
2 Rewards
View Full Analysis

Tdspharm Co., Ltd. Key Details

₩32.9b

Revenue

₩23.7b

Cost of Revenue

₩9.2b

Gross Profit

₩4.0b

Other Expenses

₩5.2b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
932.11
27.94%
15.67%
30.7%
View Full Analysis

About A464280

Founded
2002
Employees
n/a
CEO
Cheoljun Kim
WebsiteView website
www.tdspharm.com

Tdspharm Co., Ltd. researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally. It offers general medicines, prescription drugs, and non-medicinal products. The company was founded in 2002 and is based in Seongnam-si, South Korea.

Recent A464280 News & Updates

Recent updates

No updates

Tdspharm Co., Ltd. Competitors

A207940 logo

Samsung BiologicsLtd

Symbol: KOSE:A207940
Market cap: ₩65.8t
A068270 logo

Celltrion

Symbol: KOSE:A068270
Market cap: ₩43.4t
A196170 logo

ALTEOGEN

Symbol: KOSDAQ:A196170
Market cap: ₩19.3t
A0126Z0 logo

Samsung Epis Holdings

Symbol: KOSE:A0126Z0
Market cap: ₩8.7t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide